News Announcement

Biocon: Announcement under Regulation 30 (LODR)-Press Release / Media Release

Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find enclosed the press release titled Biocon and Mylan Announce U.S. FDA Approval of Semglee? (insulin glargine injection).

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds